Osteoclast precursors: cytokine-stimulated immunomodulators of inflammatory bone disease.
about
Induction of apoptosis of human primary osteoclasts treated with extracts from the medicinal plant Emblica officinalisIdentification of the homeobox protein Prx1 (MHox, Prrx-1) as a regulator of osterix expression and mediator of tumor necrosis factor α action in osteoblast differentiationEffects of anti-tumor necrosis factor α agents on boneFeedback inhibition of osteoclastogenesis during inflammation by IL-10, M-CSF receptor shedding, and induction of IRF8Hematopoietic Stem Cell Regulation by Type I and II Interferons in the Pathogenesis of Acquired Aplastic AnemiaMelatonin: a novel indolamine in oral health and diseaseHistone deacetylase 3 supports endochondral bone formation by controlling cytokine signaling and matrix remodeling.Associations of alcohol use with radiographic disease progression in African Americans with recent-onset rheumatoid arthritis.Dissecting the role of bone marrow stromal cells on bone metastases.Cross talk between the bone and immune systems: osteoclasts function as antigen-presenting cells and activate CD4+ and CD8+ T cellsProteomic analysis of bone marrow-adherent cells in rheumatoid arthritis and osteoarthritis.Cytokine-mediated bone destruction in rheumatoid arthritis.Glucocorticoids and tumor necrosis factor α increase oxidative stress and suppress Wnt protein signaling in osteoblastsTNF-induced osteoclastogenesis and inflammatory bone resorption are inhibited by transcription factor RBP-J.Incident Vertebral Fractures and Risk Factors in the First Three Years Following Glucocorticoid Initiation Among Pediatric Patients With Rheumatic DisordersAugmented LPS responsiveness in type 1 diabetes-derived osteoclasts.ARTD1 regulates osteoclastogenesis and bone homeostasis by dampening NF-κB-dependent transcription of IL-1βAdvances in osteoclast biology reveal potential new drug targets and new roles for osteoclastsTNF inhibits production of stromal cell-derived factor 1 by bone stromal cells and increases osteoclast precursor mobilization from bone marrow to peripheral blood.Melatonin: potential functions in the oral cavity.Dendritic cell-mediated in vivo bone resorption.The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis.Bone effects of biologic drugs in rheumatoid arthritis.Selective inhibition of RANK blocks osteoclast maturation and function and prevents bone loss in mice.Basic biology of skeletal aging: role of stress response pathways.NF-kappaB p100 limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism.NOTCHing the bone: insights into multi-functionality.MKP-1 signaling events are required for early osteoclastogenesis in lineage defined progenitor populations by disrupting RANKL-induced NFATc1 nuclear translocation.Osteoclasts have multiple roles in bone in addition to bone resorption.Lymphangiogenesis, myeloid cells and inflammation.Macrophage subsets and osteoimmunology: tuning of the immunological recognition and effector systems that maintain alveolar bone.The Bone Microenvironment: a Fertile Soil for Tumor Growth.Pediatric Osteoporosis: Diagnosis and Treatment Considerations.TNF and Bone Remodeling.Effects of Porphyromonas gingivalis surface-associated material on osteoclast formation.Deletion of calponin 2 in macrophages attenuates the severity of inflammatory arthritis in mice.VEGF-C, a lymphatic growth factor, is a RANKL target gene in osteoclasts that enhances osteoclastic bone resorption through an autocrine mechanism.Identification of novel genetic loci for osteoporosis and/or rheumatoid arthritis using cFDR approach.Cellular mechanism of decreased bone in Brtl mouse model of OI: imbalance of decreased osteoblast function and increased osteoclasts and their precursors.The role of bone marrow edema and lymphangiogenesis in inflammatory-erosive arthritis.
P2860
Q21254649-7834FFF5-1B76-4ADA-BE2A-0FE94B0DB423Q24635851-4BC52F87-B2B4-4196-8B18-84D2084955BDQ26851274-D0924CEB-9C4C-41CA-9DAF-334D8375E57FQ26863571-65414363-54C6-4867-800E-0D65E81FC06BQ28071495-66E0B0D6-209F-479E-8022-13F543879C81Q28387301-DA417208-CAEB-4EDA-B161-D4B44E90EDE3Q33614697-0E1CDC5C-0C66-478B-B880-64E442AD988CQ33632098-0D928C9C-94B1-4FB5-A629-364F07A48360Q33904588-24740CCA-C4AA-4C15-8E0A-3A28B787CC71Q34022425-7604022A-21A4-402F-B556-B3ED02BEF03BQ34214030-FDA31885-D086-4B30-B2E3-572630F9B586Q34252489-2034C7DB-EDD4-4D26-817A-F121E2FF1550Q35639657-9FA43275-E70F-4D2A-A72C-39A74E491075Q35760837-EFFF8FF4-F66D-4277-9527-E8EF17598618Q36016387-F4D1D807-29B0-4437-9AE8-E783F9AD2ECFQ36315765-5C900720-F7BF-4502-9B92-3E1FEFEBDD58Q36588658-7A78B601-32A2-42C9-8E46-202FC0AC1807Q36733053-B22AEBF6-7576-425E-96A1-9BFBD494C54AQ36757010-DDF6D052-9C4F-4654-AA94-7CFD0988ACABQ36835794-E328F8DD-B0C0-43B9-968E-1C43772E9BFDQ36838568-AE3AEAB0-6865-47ED-967F-D16015D3EFB3Q36955377-DB531149-F0B3-4C0A-83D6-FCF7321FD798Q36995387-A3024355-BFB1-4A05-BE98-B296B860E009Q37143375-20ACCBEF-989B-4AA0-B908-FF3D25E9FCCCQ37189212-D8C04D96-DF12-48E2-B682-9B4748D3519CQ37363042-2A44FEB6-6CB7-4099-BBCC-7495B5B4A74CQ37516656-3FA5CCF0-DD7E-42D2-A5AD-C289D63C91DEQ37622034-DC2D9D3D-F90C-41A3-A6CC-999B1D9B3F26Q37626090-DDEF1B94-90D7-4D1A-AD48-C7145D579E0AQ37754580-EA3A5D4B-D9DA-466E-BCFE-763904B5F044Q38127779-9321CD1F-D9A5-447C-840A-723B89BE39DAQ38851859-4C500998-1231-43F7-B666-F5A18A2C6286Q38921958-6AF1B509-8A7B-4366-8EF9-599158AA7507Q39287117-6E8AE36A-38C6-40D5-881B-F55194B01075Q39344809-908BC9C0-1FB6-410D-988A-2E368274DF44Q39527412-4B2EA750-4DF7-4545-AB31-89D0D91FC805Q39647223-2F5AA8F3-54E4-4FD0-AC7A-ADA537C5D10EQ41561680-D2B412E2-26E3-4A1F-B2AF-64542E5B54CFQ41875199-ACFAD23B-66D2-457C-9A09-6C183106967BQ41973199-81EC3741-C204-4F52-8A7A-562CE5BA2CE0
P2860
Osteoclast precursors: cytokine-stimulated immunomodulators of inflammatory bone disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Osteoclast precursors: cytokine-stimulated immunomodulators of inflammatory bone disease.
@ast
Osteoclast precursors: cytokine-stimulated immunomodulators of inflammatory bone disease.
@en
type
label
Osteoclast precursors: cytokine-stimulated immunomodulators of inflammatory bone disease.
@ast
Osteoclast precursors: cytokine-stimulated immunomodulators of inflammatory bone disease.
@en
prefLabel
Osteoclast precursors: cytokine-stimulated immunomodulators of inflammatory bone disease.
@ast
Osteoclast precursors: cytokine-stimulated immunomodulators of inflammatory bone disease.
@en
P2093
P1476
Osteoclast precursors: cytokine-stimulated immunomodulators of inflammatory bone disease.
@en
P2093
Brendan F Boyce
Edward M Schwarz
Lianping Xing
P304
P356
10.1097/01.BOR.0000231913.32364.32
P577
2006-07-01T00:00:00Z